ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.

导出 OA

翻译打印收藏纠错

第一作者： Samira A,Brooks

第一单位： UNC Lineberger Cancer Center, Chapel Hill, NC, USA.

作者： Samira A,Brooks ^[1] ; A Rose,Brannon ^[2] ; Joel S,Parker ^[1] ; Jennifer C,Fisher ^[1] ; Oishee,Sen ^[1] ; Michael W,Kattan ^[3] ; A Ari,Hakimi ^[4] ; James J,Hsieh ^[4] ; Toni K,Choueiri ^[5] ; Pheroze,Tamboli ^[6] ; Jodi K,Maranchie ^[7] ; Peter,Hinds ^[7] ; C Ryan,Miller ^[8] ; Matthew E,Nielsen ^[9] ; W Kimryn,Rathmell ^[10]

作者单位： UNC Lineberger Cancer Center, Chapel Hill, NC, USA. ^[1] UNC Lineberger Cancer Center, Chapel Hill, NC, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[2] Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. ^[3] Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, USA. ^[4] Department of Medical Oncology and Kidney Cancer Center, Dana Farber Cancer Institute, Boston, MA, USA. ^[5] Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. ^[6] Department of Urologic Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. ^[7] UNC Lineberger Cancer Center, Chapel Hill, NC, USA; Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. ^[8] UNC Lineberger Cancer Center, Chapel Hill, NC, USA; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. ^[9] UNC Lineberger Cancer Center, Chapel Hill, NC, USA; Department of Medicine, Division of Hematology and Oncology, and Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: Rathmell@med.unc.edu. ^[10]

关键词 Biomarker Kidney cancer Prognosis Renal cell carcinoma TCGA ccRCC